1.
Enhanced Antitumor Efficacy of Gemcitabine through Dual-Responsive Nanoparticle-Mediated Therapy in Pancreatic Cancer. J. Can. Res. Updates. 2026;15(3):186-196. doi:10.30683/1929-2279.2026.15.17